IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis.

Journal: Cancer Cell

Published: 2020-07-06

DOI: 10.1016/j.ccell.2020.06.007

Affiliations: 12

Authors: 23

Go to article
Institutions Share
Cancer Research UK Cambridge Institute (CRUK-CI), University of Cambridge, United Kingdom (UK) 0.64
EPFL Swiss Institute for Experimental Cancer Research (ISREC), Switzerland 0.09
Division of Cancer and Stem Cells, UoN, United Kingdom (UK) 0.07
Biodiscovery Institute, UoN, United Kingdom (UK) 0.07
Addenbrooke's Hospital, United Kingdom (UK) 0.04
Division of Oncogenomics, NKI, Netherlands 0.03
Oncode Institute, Netherlands 0.03
Department of Pathology, University of Cambridge, United Kingdom (UK) 0.01
Laboratory of Chemical Biology, TU/e, Netherlands 0.01
Institute for Complex Molecular Systems (ICMS), TU/e, Netherlands 0.01
Department of Biomedical Engineering, TU/e, Netherlands 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER